The Journal of head trauma rehabilitation
-
J Head Trauma Rehabil · Sep 2015
ReviewAwareness Deficits in Children and Adolescents After Traumatic Brain Injury: A Systematic Review.
To systematically review empirical research on awareness deficits in children and adolescents following traumatic brain injury (TBI). ⋯ Further research focusing on factors contributing to awareness deficits following pediatric TBI, the course of recovery, and relation to functional outcomes is warranted.
-
J Head Trauma Rehabil · Sep 2015
Comparative StudyParoxysmal Sympathetic Hyperactivity in Pediatric Rehabilitation: Clinical Factors and Acute Pharmacological Management.
Paroxysmal sympathetic hyperactivity (PSH) is widely described as occurring during intensive care, but in a number of patients it may last longer into the rehabilitation phase. Furthermore, drug therapy has been based on isolated observations. In this study, our aims are to describe a group of 26 pediatric rehabilitation patients with PSH and to quantify the effect of several drugs used to suppress PSH episodes. ⋯ PSH, whether causative or not, is associated with a worse long-term course in rehabilitation. Clinical management of PSH may be helped by a number of acutely administered drug therapies.
-
J Head Trauma Rehabil · Sep 2015
Comparative StudySubstance Use and Related Harms Among Adolescents With and Without Traumatic Brain Injury.
The relationship between self-reported lifetime traumatic brain injury (TBI) and drug and alcohol use and associated harms was examined using an epidemiological sample of Canadian adolescents. ⋯ There are strong and demographically stable associations between TBI and substance use. These associations may not only increase the odds of injury but impair the quality of postinjury recovery.
-
J Head Trauma Rehabil · Jul 2015
ReviewA Systematic Review of the Benefits and Risks of Anticoagulation Following Traumatic Brain Injury.
To synthesize the existing literature on benefits and risks of anticoagulant use after traumatic brain injury (TBI). ⋯ Pharmacological thromboprophylaxis appears to be safe among TBI patients with stabilized hemorrhagic patterns. More evidence is needed regarding effectiveness of PTP in preventing venous thromboembolism as well as preferred agent, dose, and timing for PTP.